If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Share News (CSRT)

  • There is currently no data for CSRT

BP non-exec increases stake

Wed, 31st Mar 2010 16:27
On Monday, BP non-executive director George David acquired 18,815 ADSs in the oil and gas giant for $56.89 each, followed by a further 1,185 ADSs at the same price the following day. This equates to 120,000 ordinary shares in total. The equivalent share price is 568.9p. This takes David's stake in BP to 159,000 shares. David was appointed as a non-executive director of BP in February 2008. Up until that time he had been chief executive of United Technologies Corporation. David is a member of the chairman's, the remuneration and audit committees.Russian joint venture TNK-BP says that it will spend $400m on exploration in 2010. Earlier this month, BP acquired assets in Brazil, Azerbaijan and the Gulf of Mexico from Devon Energy for $7bn. The deal included the the BP-operated Azeri-Chirag-Gunashli (ACG) development in the Caspian Sea, Azerbaijan.BP also said it intended to sell a 50% stake in its Kirby oil sands interests in Alberta, Canada to Devon, for $500m. The companies have agreed to form a 50/50 joint venture, operated by Devon, to develop the area, with Devon committing an additional $150m of capital costs on BP's behalf.BP has announced the closure of its solar manufacturing plant in the US. Top Director BuysBP (BP.) Director name: Mr George DavidAmount purchased: 112,890 @ 568.90p Value: £642,231Psion (PON) Director name: Mr Ross K GrahamAmount purchased: 58,354 @ 84.96p Value: £49,578BP (BP.) Director name: Mr David JacksonAmount purchased: 7,110 @ 568.90p Value: £40,449DataCash Group (DATA) Director name: Mr David BaileyAmount purchased: 20,000 @ 193.00p Value: £38,600Invista European Real Estate Trust (IERE) Director name: Mr Tom ChandosAmount purchased: 150,000 @ 20.00p Value: £30,000Inland (INL) Director name: Mr Stephen Desmond WicksAmount purchased: 150,000 @ 19.50p Value: £29,250Consort Medical (CSRT) Director name: Mr Toby WoolrychAmount purchased: 6,518 @ 364.34p Value: £23,748Solomon Gold (SOLG) Director name: Mr John BovardAmount purchased: 300,000 @ 7.50p Value: £22,500Goodwin Plc (GDWN) Director name: Mr Matthew Stanley GoodwinAmount purchased: 1,573 @ 1,225.02p Value: £19,270Telecom Plus (TEP) Director name: Mr Keith StellaAmount purchased: 4,372 @ 299.00p Value: £13,072Top Director SellsCobham (COB) Director name: Mr Andrew StevensAmount sold: 56,284 @ 262.85p Value: £147,942Premier Oil (PMO) Director name: Mr Andrew LodgeAmount sold: 2,678 @ 1,230.97p Value: £32,965office2office (OFF) Director name: Mr Simon MoateAmount sold: 8,467 @ 153.00p Value: £12,955Robert Wiseman (RWD) Director name: Mr Martyn MulcahyAmount sold: 2,500 @ 503.00p Value: £12,575Robert Wiseman (RWD) Director name: Mr Martyn MulcahyAmount sold: 2,500 @ 503.00p Value: £12,575

Related News

JERA Nex BP raises stakes in two Belgian offshore wind farms
15 mins ago

JERA Nex BP raises stakes in two Belgian offshore wind farms

LONDON, July ​3 (Reuters) - ⁠Offshore wind energy ​operator JERA Nex BP has increased its shareholding ​in ‌two Belgian offshore wind farms after acqu...

WINNERS & LOSERS: PPHE Hotel ends sales process; CMC Markets rises
16 hours ago

WINNERS & LOSERS: PPHE Hotel ends sales process; CMC Markets rises

(Alliance News) - The following are the leading risers and fallers among FTSE 100 and 250 index constituents on Thursday.

London's FTSE 100 inches lower as Middle East concerns weigh
1 day ago

London's FTSE 100 inches lower as Middle East concerns weigh

July 1 (Reuters) - The UK's ​blue-chip ⁠FTSE 100 slipped on Wednesday, with ​healthcare and energy shares leading declines, as investors monitored the...

CSRT.L News

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition
17 Feb 2020

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Recipharm Holds 91% Consort Stake, To Implement Compulsory Acquisition

Monday broker round-up
10 Feb 2020

Monday broker round-up

(Sharecast News) - Consort Medical: RBC Capital Markets upgrades to sector performer with a target price of 1,010p.

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional
4 Feb 2020

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm Lowers Acceptance Condition; Consort Offer Now Unconditional

Recipharm To Make No Further Changes To Consort Medical Offer
29 Jan 2020

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm To Make No Further Changes To Consort Medical Offer

Recipharm Extends Consort Medical Offer Deadline To February 4
24 Jan 2020

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Extends Consort Medical Offer Deadline To February 4

Recipharm Buys 10% Of Takeover Target Consort Medical
22 Jan 2020

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm Buys 10% Of Takeover Target Consort Medical

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle
14 Jan 2020

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Recipharm's Consort Medical Takeover Clears German Regulatory Hurdle

Friday broker round-up
10 Jan 2020

Friday broker round-up

(Sharecast News) - Polymetal International: Berenberg upgrades to buy with a target price of 1,480p.